Drug Profile
Research programme: synthetic hepatitis B DNA vaccine - Aldevron/CytoGenix
Alternative Names: Synthetic HBV DNA vaccine - Aldevron/ CytogenixLatest Information Update: 08 Jun 2010
Price :
$50
*
At a glance
- Originator Aldevron LLC; CytoGenix
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hepatitis B
Most Recent Events
- 01 Sep 2005 Preclinical trials in Hepatitis B in USA (unspecified route)